We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Novartis, Elan Sue IPC Over Generic Focalin XR

Law360 (March 30, 2011, 5:59 PM EDT) -- Novartis Pharma AG and Elan Corp. PLC slapped Intellipharmaceutics Corp. with patent infringement suits in New Jersey and Delaware on Friday over the company's efforts to market a generic version of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.